TrialEpilepsia2025

Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years.

Eric B Segal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.